HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The aryl hydrocarbon receptor maintains antitumor activity of liver resident natural killer cells after partial hepatectomy in C57BL/6J mice.

AbstractBACKGROUND:
Liver-resident natural killer (lr-NK) cells are distinct from conventional NK cells and exhibit higher cytotoxicity against hepatoma via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). However, the mechanism by which partial hepatectomy (PH) significantly suppresses TRAIL expression in lr-NK cells remains unclear.
METHODS:
This study aimed to investigate the PH influence on the function and characteristics of liver-resident NK (lr-NK) cells using a PH mouse model.
RESULTS:
Here, we report that PH alters the differentiation pattern of NK cells in the liver, and an aryl hydrocarbon receptor (AhR) molecule is involved in these changes. Treatment with the AhR agonist 6-formylindolo[3,2-b]carbazole (FICZ) inhibited the maturation of NK cells. FICZ increased the immature subtype proportion of NK cells with high TRAIL activity and decreased the mature subtype of NK cells with low TRAIL activity. Consequently, FICZ increased the expression of TRAIL and cytotoxic activity of NK cells in the liver, and this effect was confirmed even after hepatectomy. The participation of AhR promoted FoxO1 expression in the mTOR signaling pathway involved in the maturation of NK cells, resulting in TRAIL expression.
CONCLUSION:
Our findings provide direct in-vivo evidence that partial hepatectomy affects lrNK cell activity through NK cell differentiation in the liver. Perioperative therapies using an AhR agonist to improve NK cell function may reduce the recurrence of hepatocellular carcinoma after hepatectomy.
AuthorsKoki Sato, Masahiro Ohira, Yuki Imaoka, Kouki Imaoka, Tomoaki Bekki, Marlen Doskali, Ryosuke Nakano, Takuya Yano, Yuka Tanaka, Hideki Ohdan
JournalCancer medicine (Cancer Med) Vol. 12 Issue 19 Pg. 19821-19837 (10 2023) ISSN: 2045-7634 [Electronic] United States
PMID37747052 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2023 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
Chemical References
  • Receptors, Aryl Hydrocarbon
  • TNF-Related Apoptosis-Inducing Ligand
  • Tumor Necrosis Factor-alpha
Topics
  • Animals
  • Mice
  • Carcinoma, Hepatocellular (immunology, surgery)
  • Hepatectomy
  • Killer Cells, Natural (immunology)
  • Mice, Inbred C57BL
  • Receptors, Aryl Hydrocarbon (analysis, metabolism)
  • TNF-Related Apoptosis-Inducing Ligand (pharmacology)
  • Tumor Necrosis Factor-alpha (metabolism)
  • Liver Neoplasms (immunology, surgery)
  • Neoplasm Recurrence, Local (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: